With 66.91 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.26 million shares. The 52-week range on BBAI shows that it touched its highest point at $4.18 and its lowest point at $1.16 during that stretch. It currently has a 1-year price target of $3.38. Beta for the stock currently stands at 3.49.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BBAI was up-trending over the past week, with a rise of 73.90%, but this was up by 162.42% over a month. Three-month performance surged to 154.71% while six-month performance rose 164.02%. The stock gained 52.46% in the past year, while it has gained 102.34% so far this year. A look at the trailing 12-month EPS for BBAI yields -0.54 with Next year EPS estimates of -0.21. For the next quarter, that number is -0.05. This implies an EPS growth rate of 70.53% for this year and 23.57% for next year.
Float and Shares Shorts:
At present, 117.07 million BBAI shares are outstanding with a float of 50.38 million shares on hand for trading. On Feb 15, 2024, short shares totaled 9.8 million, which was 6.22% higher than short shares on Jan 12, 2024. In addition to BBAI as the firm’s BigBear.ai, Inc., BTAI serves as its BioXcel Therapeutics, Inc.
Institutional Ownership:
Through their ownership of 7.53% of BBAI’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BBAI since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
Summary of Insider Activity:
Insiders traded BBAI stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 16 while that of sell transactions has risen to 33 over the past year. The total number of shares bought during that period was 1,583,927 while 11,034,248 shares were sold.
